沪深市场个股详情

宣泰医药 (688247)

添加自选
  • 9.30
  • +0.14+1.53%
已收盘 04/30 15:00 (北京)
42.16亿总市值96.88市盈率TTM

宣泰医药 (688247) 利润表

全部
显示同比 yoy
隐藏空行 yoy
(Q1)2026/03/31
(FY)2025/12/31
(Q9)2025/09/30
(Q6)2025/06/30
(Q1)2025/03/31
(FY)2024/12/31
(Q9)2024/09/30
(Q6)2024/06/30
(Q1)2024/03/31
(FY)2023/12/31
营业总收入
-13.20%9,454.67万
-12.71%4.47亿
-8.59%3.31亿
0.74%2.2亿
-2.23%1.09亿
70.61%5.12亿
69.95%3.63亿
96.81%2.18亿
162.65%1.11亿
21.13%3亿
营业收入
-13.20%9,454.67万
-12.71%4.47亿
-8.59%3.31亿
0.74%2.2亿
-2.23%1.09亿
70.61%5.12亿
69.95%3.63亿
96.81%2.18亿
162.65%1.11亿
21.13%3亿
营业总成本
-7.31%8,243.2万
2.68%3.94亿
3.78%2.77亿
8.06%1.78亿
3.95%8,893.63万
56.11%3.84亿
52.82%2.66亿
78.56%1.65亿
118.91%8,555.64万
34.11%2.46亿
营业成本
-11.83%5,769.64万
9.32%2.71亿
10.95%1.96亿
15.96%1.29亿
7.67%6,543.55万
87.10%2.47亿
67.80%1.77亿
123.11%1.11亿
227.41%6,077.39万
85.70%1.32亿
营业税金及附加
8.82%93.69万
24.71%338.34万
29.69%258.9万
35.60%158.51万
49.29%86.1万
-10.51%271.3万
228.54%199.64万
215.10%116.89万
226.27%57.67万
289.96%303.16万
销售费用
19.75%224.75万
-5.06%986.89万
13.31%774.66万
-2.34%441.94万
-14.48%187.68万
27.17%1,039.48万
22.03%683.67万
17.44%452.51万
61.07%219.46万
33.86%817.37万
管理费用
-6.55%834.39万
-17.22%3,713.16万
4.00%2,882.4万
6.51%1,864.24万
13.85%892.86万
25.44%4,485.44万
6.05%2,771.66万
5.64%1,750.3万
5.19%784.21万
-5.38%3,575.7万
财务费用
300.58%123.44万
75.73%-153.64万
49.49%-170.99万
62.43%-145.71万
52.12%-61.54万
12.58%-632.97万
50.00%-338.54万
35.96%-387.88万
-300.17%-128.53万
14.78%-724.06万
-利息费用
-50.40%81.74
-44.71%1,411.72
-48.74%1,132.17
-60.82%652.84
-82.25%164.79
-93.25%2,553.17
-93.98%2,208.77
-95.29%1,666.2
-95.06%928.65
-82.29%3.78万
-利息收入
-108.64%-147.51万
-22.86%-532.07万
-5.62%-338.16万
19.67%-183.18万
34.89%-70.7万
28.75%-433.06万
39.64%-320.18万
51.20%-228.02万
-118.33%-108.58万
-87.55%-607.78万
研发费用
-3.83%1,197.3万
-11.76%7,493.96万
-24.05%4,288.95万
-24.54%2,570.4万
-19.44%1,244.97万
14.75%8,492.47万
30.08%5,647.17万
23.39%3,406.41万
41.98%1,545.45万
-2.65%7,400.54万
信用减值损失
-28.42%146.85万
63.03%-145.3万
144.47%152.12万
301.52%169.76万
614.25%205.18万
-387.71%-393.05万
-722.69%-342.07万
-165.34%-84.24万
-124.63%-39.9万
43.52%-80.59万
资产减值损失
55.68%-23.81万
-1,181.53%-1,753.97万
-804.60%-86.54万
0.67%-101.44万
-739.66%-53.74万
205.89%162.18万
110.40%12.28万
-14.61%-102.13万
83.70%-6.4万
-159.22%-153.15万
非经营性净收益
公允价值变动净收益
----
--134.13万
----
----
----
----
----
----
----
----
投资净收益
-28.36%61.72万
-17.71%991.14万
31.26%918.18万
7.45%682.99万
-14.43%86.15万
5.94%1,204.49万
-6.99%699.51万
21.20%635.64万
-63.58%100.68万
-47.80%1,136.91万
-其中:对联营合营企业的投资收益
162.27%24.85万
98.81%111.66万
1,201.58%243.9万
6.47%156.19万
125.54%9.47万
126.27%56.17万
-75.70%18.74万
312.79%146.7万
-440.33%-37.09万
-148.29%-213.79万
资产处置收益
----
----
----
----
----
----
----
----
----
-47.20%8.21万
其他收益
-2.25%96.26万
65.20%1,081.91万
63.93%478.75万
18.80%206.67万
420.89%98.47万
8.81%654.91万
52.09%292.04万
129.26%173.97万
-62.00%18.9万
-49.41%601.87万
营业利润
-36.09%1,492.48万
-61.55%5,531.88万
-32.31%6,956.84万
-13.96%5,123.38万
-12.17%2,335.13万
108.49%1.44亿
114.58%1.03亿
138.39%5,954.83万
239.84%2,658.8万
-30.38%6,901.18万
加:营业外收入
86,024.73%346.9万
560.42%3.73万
57.92%8,763.49
565.21%5,486.5
3,038.91%4,027.85
-95.59%5,649.23
-94.72%5,549.16
-99.18%824.78
-33.18%128.32
3,949.87%12.81万
减:营业外支出
-76.45%1.85万
12.03%202.08万
-66.58%27.94万
-26.90%21.35万
-57.52%7.84万
-42.72%180.38万
637.41%83.61万
1,035.24%29.21万
--18.45万
89.78%314.91万
利润总额
-21.06%1,837.53万
-62.46%5,333.53万
-32.02%6,929.77万
-13.89%5,102.58万
-11.84%2,327.7万
115.31%1.42亿
112.89%1.02亿
136.51%5,925.7万
237.47%2,640.36万
-32.30%6,599.08万
减:所得税费用
-35.00%181.2万
-59.31%585.25万
-37.69%583.52万
6.59%544.02万
-20.53%278.77万
192.51%1,438.17万
146.35%936.45万
125.57%510.37万
3,172.12%350.77万
8.21%491.67万
净利润
-19.16%1,656.33万
-62.82%4,748.28万
-31.45%6,346.25万
-15.82%4,558.57万
-10.51%2,048.93万
109.09%1.28亿
110.00%9,257.3万
137.60%5,415.33万
196.71%2,289.59万
-34.28%6,107.41万
持续经营净利润
-19.16%1,656.33万
-62.82%4,748.28万
-31.45%6,346.25万
-15.82%4,558.57万
-10.51%2,048.93万
109.09%1.28亿
110.00%9,257.3万
137.60%5,415.33万
196.71%2,289.59万
-34.28%6,107.41万
归属于母公司所有者的净利润
-19.16%1,656.33万
-62.82%4,748.28万
-31.45%6,346.25万
-15.82%4,558.57万
-10.51%2,048.93万
109.09%1.28亿
110.00%9,257.3万
137.60%5,415.33万
196.71%2,289.59万
-34.28%6,107.41万
每股收益
基本每股收益
-20.00%0.04
-60.71%0.11
-33.33%0.14
-16.67%0.1
0.00%0.05
115.38%0.28
110.00%0.21
140.00%0.12
150.00%0.05
-40.91%0.13
稀释每股收益
-20.00%0.04
-60.71%0.11
-33.33%0.14
-16.67%0.1
0.00%0.05
115.38%0.28
110.00%0.21
140.00%0.12
150.00%0.05
-40.91%0.13
其他综合收益
-1.6万
-115.89%-2.09万
-221.98%-1.29万
110.19%357.33
630.31%13.13万
-80.38%1.06万
-105.13%-3,507.81
99.56%-107.34
-88.50%1.8万
归属于母公司所有者的其他综合收益总额
---1.6万
-115.89%-2.09万
-221.98%-1.29万
110.19%357.33
----
630.31%13.13万
-80.38%1.06万
-105.13%-3,507.81
99.56%-107.34
-88.50%1.8万
综合收益总额
-19.24%1,654.73万
-62.87%4,746.2万
-31.47%6,344.95万
-15.82%4,558.6万
-10.51%2,048.93万
109.24%1.28亿
109.77%9,258.36万
136.87%5,414.98万
197.64%2,289.58万
-34.37%6,109.2万
归属于母公司所有者的综合收益总额
-19.24%1,654.73万
-62.87%4,746.2万
-31.47%6,344.95万
-15.82%4,558.6万
-10.51%2,048.93万
109.24%1.28亿
109.77%9,258.36万
136.87%5,414.98万
197.64%2,289.58万
-34.37%6,109.2万
货币单位
人民币
人民币
人民币
人民币
人民币
人民币
人民币
人民币
人民币
人民币
会计准则
中国会计准则(2007)
中国会计准则(2007)
中国会计准则(2007)
中国会计准则(2007)
中国会计准则(2007)
中国会计准则(2007)
中国会计准则(2007)
中国会计准则(2007)
中国会计准则(2007)
中国会计准则(2007)
审计意见
--
--
--
--
--
--
--
--
--
无保留意见
会计师事务所
--
--
--
--
--
--
--
--
--
上会会计师事务所(特殊普通合伙)
(Q1)2026/03/31(FY)2025/12/31(Q9)2025/09/30(Q6)2025/06/30(Q1)2025/03/31(FY)2024/12/31(Q9)2024/09/30(Q6)2024/06/30(Q1)2024/03/31(FY)2023/12/31
营业总收入 -13.20%9,454.67万-12.71%4.47亿-8.59%3.31亿0.74%2.2亿-2.23%1.09亿70.61%5.12亿69.95%3.63亿96.81%2.18亿162.65%1.11亿21.13%3亿
营业收入 -13.20%9,454.67万-12.71%4.47亿-8.59%3.31亿0.74%2.2亿-2.23%1.09亿70.61%5.12亿69.95%3.63亿96.81%2.18亿162.65%1.11亿21.13%3亿
营业总成本 -7.31%8,243.2万2.68%3.94亿3.78%2.77亿8.06%1.78亿3.95%8,893.63万56.11%3.84亿52.82%2.66亿78.56%1.65亿118.91%8,555.64万34.11%2.46亿
营业成本 -11.83%5,769.64万9.32%2.71亿10.95%1.96亿15.96%1.29亿7.67%6,543.55万87.10%2.47亿67.80%1.77亿123.11%1.11亿227.41%6,077.39万85.70%1.32亿
营业税金及附加 8.82%93.69万24.71%338.34万29.69%258.9万35.60%158.51万49.29%86.1万-10.51%271.3万228.54%199.64万215.10%116.89万226.27%57.67万289.96%303.16万
销售费用 19.75%224.75万-5.06%986.89万13.31%774.66万-2.34%441.94万-14.48%187.68万27.17%1,039.48万22.03%683.67万17.44%452.51万61.07%219.46万33.86%817.37万
管理费用 -6.55%834.39万-17.22%3,713.16万4.00%2,882.4万6.51%1,864.24万13.85%892.86万25.44%4,485.44万6.05%2,771.66万5.64%1,750.3万5.19%784.21万-5.38%3,575.7万
财务费用 300.58%123.44万75.73%-153.64万49.49%-170.99万62.43%-145.71万52.12%-61.54万12.58%-632.97万50.00%-338.54万35.96%-387.88万-300.17%-128.53万14.78%-724.06万
-利息费用 -50.40%81.74-44.71%1,411.72-48.74%1,132.17-60.82%652.84-82.25%164.79-93.25%2,553.17-93.98%2,208.77-95.29%1,666.2-95.06%928.65-82.29%3.78万
-利息收入 -108.64%-147.51万-22.86%-532.07万-5.62%-338.16万19.67%-183.18万34.89%-70.7万28.75%-433.06万39.64%-320.18万51.20%-228.02万-118.33%-108.58万-87.55%-607.78万
研发费用 -3.83%1,197.3万-11.76%7,493.96万-24.05%4,288.95万-24.54%2,570.4万-19.44%1,244.97万14.75%8,492.47万30.08%5,647.17万23.39%3,406.41万41.98%1,545.45万-2.65%7,400.54万
信用减值损失 -28.42%146.85万63.03%-145.3万144.47%152.12万301.52%169.76万614.25%205.18万-387.71%-393.05万-722.69%-342.07万-165.34%-84.24万-124.63%-39.9万43.52%-80.59万
资产减值损失 55.68%-23.81万-1,181.53%-1,753.97万-804.60%-86.54万0.67%-101.44万-739.66%-53.74万205.89%162.18万110.40%12.28万-14.61%-102.13万83.70%-6.4万-159.22%-153.15万
非经营性净收益
公允价值变动净收益 ------134.13万--------------------------------
投资净收益 -28.36%61.72万-17.71%991.14万31.26%918.18万7.45%682.99万-14.43%86.15万5.94%1,204.49万-6.99%699.51万21.20%635.64万-63.58%100.68万-47.80%1,136.91万
-其中:对联营合营企业的投资收益 162.27%24.85万98.81%111.66万1,201.58%243.9万6.47%156.19万125.54%9.47万126.27%56.17万-75.70%18.74万312.79%146.7万-440.33%-37.09万-148.29%-213.79万
资产处置收益 -------------------------------------47.20%8.21万
其他收益 -2.25%96.26万65.20%1,081.91万63.93%478.75万18.80%206.67万420.89%98.47万8.81%654.91万52.09%292.04万129.26%173.97万-62.00%18.9万-49.41%601.87万
营业利润 -36.09%1,492.48万-61.55%5,531.88万-32.31%6,956.84万-13.96%5,123.38万-12.17%2,335.13万108.49%1.44亿114.58%1.03亿138.39%5,954.83万239.84%2,658.8万-30.38%6,901.18万
加:营业外收入 86,024.73%346.9万560.42%3.73万57.92%8,763.49565.21%5,486.53,038.91%4,027.85-95.59%5,649.23-94.72%5,549.16-99.18%824.78-33.18%128.323,949.87%12.81万
减:营业外支出 -76.45%1.85万12.03%202.08万-66.58%27.94万-26.90%21.35万-57.52%7.84万-42.72%180.38万637.41%83.61万1,035.24%29.21万--18.45万89.78%314.91万
利润总额 -21.06%1,837.53万-62.46%5,333.53万-32.02%6,929.77万-13.89%5,102.58万-11.84%2,327.7万115.31%1.42亿112.89%1.02亿136.51%5,925.7万237.47%2,640.36万-32.30%6,599.08万
减:所得税费用 -35.00%181.2万-59.31%585.25万-37.69%583.52万6.59%544.02万-20.53%278.77万192.51%1,438.17万146.35%936.45万125.57%510.37万3,172.12%350.77万8.21%491.67万
净利润 -19.16%1,656.33万-62.82%4,748.28万-31.45%6,346.25万-15.82%4,558.57万-10.51%2,048.93万109.09%1.28亿110.00%9,257.3万137.60%5,415.33万196.71%2,289.59万-34.28%6,107.41万
持续经营净利润 -19.16%1,656.33万-62.82%4,748.28万-31.45%6,346.25万-15.82%4,558.57万-10.51%2,048.93万109.09%1.28亿110.00%9,257.3万137.60%5,415.33万196.71%2,289.59万-34.28%6,107.41万
归属于母公司所有者的净利润 -19.16%1,656.33万-62.82%4,748.28万-31.45%6,346.25万-15.82%4,558.57万-10.51%2,048.93万109.09%1.28亿110.00%9,257.3万137.60%5,415.33万196.71%2,289.59万-34.28%6,107.41万
每股收益
基本每股收益 -20.00%0.04-60.71%0.11-33.33%0.14-16.67%0.10.00%0.05115.38%0.28110.00%0.21140.00%0.12150.00%0.05-40.91%0.13
稀释每股收益 -20.00%0.04-60.71%0.11-33.33%0.14-16.67%0.10.00%0.05115.38%0.28110.00%0.21140.00%0.12150.00%0.05-40.91%0.13
其他综合收益 -1.6万-115.89%-2.09万-221.98%-1.29万110.19%357.33630.31%13.13万-80.38%1.06万-105.13%-3,507.8199.56%-107.34-88.50%1.8万
归属于母公司所有者的其他综合收益总额 ---1.6万-115.89%-2.09万-221.98%-1.29万110.19%357.33----630.31%13.13万-80.38%1.06万-105.13%-3,507.8199.56%-107.34-88.50%1.8万
综合收益总额 -19.24%1,654.73万-62.87%4,746.2万-31.47%6,344.95万-15.82%4,558.6万-10.51%2,048.93万109.24%1.28亿109.77%9,258.36万136.87%5,414.98万197.64%2,289.58万-34.37%6,109.2万
归属于母公司所有者的综合收益总额 -19.24%1,654.73万-62.87%4,746.2万-31.47%6,344.95万-15.82%4,558.6万-10.51%2,048.93万109.24%1.28亿109.77%9,258.36万136.87%5,414.98万197.64%2,289.58万-34.37%6,109.2万
货币单位 人民币人民币人民币人民币人民币人民币人民币人民币人民币人民币
会计准则 中国会计准则(2007)中国会计准则(2007)中国会计准则(2007)中国会计准则(2007)中国会计准则(2007)中国会计准则(2007)中国会计准则(2007)中国会计准则(2007)中国会计准则(2007)中国会计准则(2007)
审计意见 ------------------无保留意见
会计师事务所 ------------------上会会计师事务所(特殊普通合伙)

FY:Financial Year 年度报告,相当于上市公司向SEC披露的10-K文件。

Q:Quarter 季度报告,相当于上市公司向SEC披露的10-Q文件,其中Q1、Q2、Q3、Q4为单季报,跨度为3个月;Q6、Q9为累计季报,Q6为6个月,Q9为9个月。

热门市场机会
中东战火燃至股市!投资者该如何应对?
5月1日,持续两个多月的美以伊军事冲突迎来法律节点,可能会使特朗普政府在未来几天压力增大。届时若国会未能续批授权,对伊军事行动将依法终止。此外,美伊停战又有变数!自伊朗方面获悉,伊朗已向巴基斯坦提交了其最新谈判方案文本,由巴方作为与美国进行谈判的中间人。以色列媒体报道说,美国“可 展开